Crossmark

Breaking resistance barriers: ensartinib as a milestone in anaplastic lymphoma kinase–driven non-small cell lung cancer therapy

Published Online: 2026-02-11

Authors

Gumma, Lohitha https://orcid.org/0009-0002-5196-8081
Gumma, Bhargavi

Yarrabothula, Lakshmi Prasanna
License Information

Text and Data Mining valid from 2026-02-11

Version of Record valid from 2026-02-11
More Information

Article History

Received: 1 October 2025

Accepted: 24 January 2026

First Online: 11 February 2026

Declarations

:

: Not applicable. As this is a review article, formal ethical approval was not required as per our institution’s guidelines.

: Not applicable.

: The authors declare no competing interests.

Document is current